Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes

Recurrent translocations are uncommon in myelodysplastic syndromes (MDS). Three new recurrent translocations, namely der(12)t(3;12)(q13;p13), t(11;13;22)(q13;q14;q12) and der(17)t(13;17)(q21;p13), identified by conventional cytogenetics (CC) in 4 MDS patients, were further characterized using a pane...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta haematologica 2016-01, Vol.135 (2), p.94-100
Hauptverfasser: Costa, Dolors, Muñoz, Concha, Carrió, Ana, Arias, Amparo, Gómez, Cándida, Solé, Francesc, Espinet, Blanca, Azaceta, Gemma, Calasanz, María J., Nomdedeu, Meritxell, Calvo, Xavier, Campo, Elias, Nomdedeu, Benet
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100
container_issue 2
container_start_page 94
container_title Acta haematologica
container_volume 135
creator Costa, Dolors
Muñoz, Concha
Carrió, Ana
Arias, Amparo
Gómez, Cándida
Solé, Francesc
Espinet, Blanca
Azaceta, Gemma
Calasanz, María J.
Nomdedeu, Meritxell
Calvo, Xavier
Campo, Elias
Nomdedeu, Benet
description Recurrent translocations are uncommon in myelodysplastic syndromes (MDS). Three new recurrent translocations, namely der(12)t(3;12)(q13;p13), t(11;13;22)(q13;q14;q12) and der(17)t(13;17)(q21;p13), identified by conventional cytogenetics (CC) in 4 MDS patients, were further characterized using a panel of commercial and homemade fluorescence in situ hybridization (FISH) probes. The goal of this study was to determine the precise breakpoints and to identify genes that could be related with the neoplastic process. Half of the breakpoints (4/8) were precisely identified and in the remaining half they were narrowed to a region ranging from 14 to 926 kb. All the studied breakpoints had interstitial or terminal deletions ranging from 536 kb to 89 Mb, and only those 7 Mb were detected by CC. The genes located in or around the breakpoints described in our study have not been previously related to MDS. The deleted regions include the ETV6 and RB1 genes, among others, and exclude the TP53 gene. FISH studies were useful to refine the breakpoints of the translocations, but further studies are needed to determine the role of the involved genes in the neoplastic process.
doi_str_mv 10.1159/000439161
format Article
fullrecord <record><control><sourceid>pubmed_karge</sourceid><recordid>TN_cdi_pubmed_primary_26509426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>26509426</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-f95b2d8d4309586fddc74f30786736dd9daccd2df27b1082fc559cd12956a0d03</originalsourceid><addsrcrecordid>eNo90M9LwzAUB_AgipvTg3eRXD1Uk7RJm6MOfwymgtabULK8ZIvr0pJUpP-9lc2dHu_x-b7DF6FzSq4p5fKGEJKlkgp6gMY0YzSRQrBDNB7uNOG5ZCN0EuPXsLE8lcdoxAQnMmNijD7fjHXe-SXuVgbfBaPWbeN8F3FjcbkKxuAX84PLoHysG6061_iIZ2B856wzgJ3Hz72pG-hjW6vYOY3few-h2Zh4io6sqqM5280J-ni4L6dPyfz1cTa9nSc6zUWXWMkXDArIUiJ5ISyAzjObkrwQeSoAJCitgYFl-YKSglnNudRAmeRCESDpBF1t_-rQxBiMrdrgNir0FSXVX0PVvqHBXm5t-73YGNjL_0oGcLEFaxWWJuzBLv8LFdNq0w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes</title><source>MEDLINE</source><source>Karger Journals</source><creator>Costa, Dolors ; Muñoz, Concha ; Carrió, Ana ; Arias, Amparo ; Gómez, Cándida ; Solé, Francesc ; Espinet, Blanca ; Azaceta, Gemma ; Calasanz, María J. ; Nomdedeu, Meritxell ; Calvo, Xavier ; Campo, Elias ; Nomdedeu, Benet</creator><creatorcontrib>Costa, Dolors ; Muñoz, Concha ; Carrió, Ana ; Arias, Amparo ; Gómez, Cándida ; Solé, Francesc ; Espinet, Blanca ; Azaceta, Gemma ; Calasanz, María J. ; Nomdedeu, Meritxell ; Calvo, Xavier ; Campo, Elias ; Nomdedeu, Benet</creatorcontrib><description>Recurrent translocations are uncommon in myelodysplastic syndromes (MDS). Three new recurrent translocations, namely der(12)t(3;12)(q13;p13), t(11;13;22)(q13;q14;q12) and der(17)t(13;17)(q21;p13), identified by conventional cytogenetics (CC) in 4 MDS patients, were further characterized using a panel of commercial and homemade fluorescence in situ hybridization (FISH) probes. The goal of this study was to determine the precise breakpoints and to identify genes that could be related with the neoplastic process. Half of the breakpoints (4/8) were precisely identified and in the remaining half they were narrowed to a region ranging from 14 to 926 kb. All the studied breakpoints had interstitial or terminal deletions ranging from 536 kb to 89 Mb, and only those 7 Mb were detected by CC. The genes located in or around the breakpoints described in our study have not been previously related to MDS. The deleted regions include the ETV6 and RB1 genes, among others, and exclude the TP53 gene. FISH studies were useful to refine the breakpoints of the translocations, but further studies are needed to determine the role of the involved genes in the neoplastic process.</description><identifier>ISSN: 0001-5792</identifier><identifier>EISSN: 1421-9662</identifier><identifier>DOI: 10.1159/000439161</identifier><identifier>PMID: 26509426</identifier><language>eng</language><publisher>Basel, Switzerland</publisher><subject>Aged ; Aged, 80 and over ; Chromosome Mapping ; ETS Translocation Variant 6 Protein ; Female ; Humans ; In Situ Hybridization, Fluorescence ; Karyotyping ; Male ; Middle Aged ; Myelodysplastic Syndromes - genetics ; Myelodysplastic Syndromes - pathology ; Original Paper ; Proto-Oncogene Proteins c-ets - genetics ; Repressor Proteins - genetics ; Retinoblastoma Protein - genetics ; Translocation, Genetic ; Tumor Suppressor Protein p53 - genetics</subject><ispartof>Acta haematologica, 2016-01, Vol.135 (2), p.94-100</ispartof><rights>2015 S. Karger AG, Basel</rights><rights>2015 S. Karger AG, Basel.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-f95b2d8d4309586fddc74f30786736dd9daccd2df27b1082fc559cd12956a0d03</citedby><cites>FETCH-LOGICAL-c376t-f95b2d8d4309586fddc74f30786736dd9daccd2df27b1082fc559cd12956a0d03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,2431,27931,27932</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26509426$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Costa, Dolors</creatorcontrib><creatorcontrib>Muñoz, Concha</creatorcontrib><creatorcontrib>Carrió, Ana</creatorcontrib><creatorcontrib>Arias, Amparo</creatorcontrib><creatorcontrib>Gómez, Cándida</creatorcontrib><creatorcontrib>Solé, Francesc</creatorcontrib><creatorcontrib>Espinet, Blanca</creatorcontrib><creatorcontrib>Azaceta, Gemma</creatorcontrib><creatorcontrib>Calasanz, María J.</creatorcontrib><creatorcontrib>Nomdedeu, Meritxell</creatorcontrib><creatorcontrib>Calvo, Xavier</creatorcontrib><creatorcontrib>Campo, Elias</creatorcontrib><creatorcontrib>Nomdedeu, Benet</creatorcontrib><title>Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes</title><title>Acta haematologica</title><addtitle>Acta Haematol</addtitle><description>Recurrent translocations are uncommon in myelodysplastic syndromes (MDS). Three new recurrent translocations, namely der(12)t(3;12)(q13;p13), t(11;13;22)(q13;q14;q12) and der(17)t(13;17)(q21;p13), identified by conventional cytogenetics (CC) in 4 MDS patients, were further characterized using a panel of commercial and homemade fluorescence in situ hybridization (FISH) probes. The goal of this study was to determine the precise breakpoints and to identify genes that could be related with the neoplastic process. Half of the breakpoints (4/8) were precisely identified and in the remaining half they were narrowed to a region ranging from 14 to 926 kb. All the studied breakpoints had interstitial or terminal deletions ranging from 536 kb to 89 Mb, and only those 7 Mb were detected by CC. The genes located in or around the breakpoints described in our study have not been previously related to MDS. The deleted regions include the ETV6 and RB1 genes, among others, and exclude the TP53 gene. FISH studies were useful to refine the breakpoints of the translocations, but further studies are needed to determine the role of the involved genes in the neoplastic process.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Chromosome Mapping</subject><subject>ETS Translocation Variant 6 Protein</subject><subject>Female</subject><subject>Humans</subject><subject>In Situ Hybridization, Fluorescence</subject><subject>Karyotyping</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myelodysplastic Syndromes - genetics</subject><subject>Myelodysplastic Syndromes - pathology</subject><subject>Original Paper</subject><subject>Proto-Oncogene Proteins c-ets - genetics</subject><subject>Repressor Proteins - genetics</subject><subject>Retinoblastoma Protein - genetics</subject><subject>Translocation, Genetic</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><issn>0001-5792</issn><issn>1421-9662</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo90M9LwzAUB_AgipvTg3eRXD1Uk7RJm6MOfwymgtabULK8ZIvr0pJUpP-9lc2dHu_x-b7DF6FzSq4p5fKGEJKlkgp6gMY0YzSRQrBDNB7uNOG5ZCN0EuPXsLE8lcdoxAQnMmNijD7fjHXe-SXuVgbfBaPWbeN8F3FjcbkKxuAX84PLoHysG6061_iIZ2B856wzgJ3Hz72pG-hjW6vYOY3few-h2Zh4io6sqqM5280J-ni4L6dPyfz1cTa9nSc6zUWXWMkXDArIUiJ5ISyAzjObkrwQeSoAJCitgYFl-YKSglnNudRAmeRCESDpBF1t_-rQxBiMrdrgNir0FSXVX0PVvqHBXm5t-73YGNjL_0oGcLEFaxWWJuzBLv8LFdNq0w</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Costa, Dolors</creator><creator>Muñoz, Concha</creator><creator>Carrió, Ana</creator><creator>Arias, Amparo</creator><creator>Gómez, Cándida</creator><creator>Solé, Francesc</creator><creator>Espinet, Blanca</creator><creator>Azaceta, Gemma</creator><creator>Calasanz, María J.</creator><creator>Nomdedeu, Meritxell</creator><creator>Calvo, Xavier</creator><creator>Campo, Elias</creator><creator>Nomdedeu, Benet</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20160101</creationdate><title>Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes</title><author>Costa, Dolors ; Muñoz, Concha ; Carrió, Ana ; Arias, Amparo ; Gómez, Cándida ; Solé, Francesc ; Espinet, Blanca ; Azaceta, Gemma ; Calasanz, María J. ; Nomdedeu, Meritxell ; Calvo, Xavier ; Campo, Elias ; Nomdedeu, Benet</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-f95b2d8d4309586fddc74f30786736dd9daccd2df27b1082fc559cd12956a0d03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Chromosome Mapping</topic><topic>ETS Translocation Variant 6 Protein</topic><topic>Female</topic><topic>Humans</topic><topic>In Situ Hybridization, Fluorescence</topic><topic>Karyotyping</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myelodysplastic Syndromes - genetics</topic><topic>Myelodysplastic Syndromes - pathology</topic><topic>Original Paper</topic><topic>Proto-Oncogene Proteins c-ets - genetics</topic><topic>Repressor Proteins - genetics</topic><topic>Retinoblastoma Protein - genetics</topic><topic>Translocation, Genetic</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Costa, Dolors</creatorcontrib><creatorcontrib>Muñoz, Concha</creatorcontrib><creatorcontrib>Carrió, Ana</creatorcontrib><creatorcontrib>Arias, Amparo</creatorcontrib><creatorcontrib>Gómez, Cándida</creatorcontrib><creatorcontrib>Solé, Francesc</creatorcontrib><creatorcontrib>Espinet, Blanca</creatorcontrib><creatorcontrib>Azaceta, Gemma</creatorcontrib><creatorcontrib>Calasanz, María J.</creatorcontrib><creatorcontrib>Nomdedeu, Meritxell</creatorcontrib><creatorcontrib>Calvo, Xavier</creatorcontrib><creatorcontrib>Campo, Elias</creatorcontrib><creatorcontrib>Nomdedeu, Benet</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Acta haematologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Costa, Dolors</au><au>Muñoz, Concha</au><au>Carrió, Ana</au><au>Arias, Amparo</au><au>Gómez, Cándida</au><au>Solé, Francesc</au><au>Espinet, Blanca</au><au>Azaceta, Gemma</au><au>Calasanz, María J.</au><au>Nomdedeu, Meritxell</au><au>Calvo, Xavier</au><au>Campo, Elias</au><au>Nomdedeu, Benet</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes</atitle><jtitle>Acta haematologica</jtitle><addtitle>Acta Haematol</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>135</volume><issue>2</issue><spage>94</spage><epage>100</epage><pages>94-100</pages><issn>0001-5792</issn><eissn>1421-9662</eissn><abstract>Recurrent translocations are uncommon in myelodysplastic syndromes (MDS). Three new recurrent translocations, namely der(12)t(3;12)(q13;p13), t(11;13;22)(q13;q14;q12) and der(17)t(13;17)(q21;p13), identified by conventional cytogenetics (CC) in 4 MDS patients, were further characterized using a panel of commercial and homemade fluorescence in situ hybridization (FISH) probes. The goal of this study was to determine the precise breakpoints and to identify genes that could be related with the neoplastic process. Half of the breakpoints (4/8) were precisely identified and in the remaining half they were narrowed to a region ranging from 14 to 926 kb. All the studied breakpoints had interstitial or terminal deletions ranging from 536 kb to 89 Mb, and only those 7 Mb were detected by CC. The genes located in or around the breakpoints described in our study have not been previously related to MDS. The deleted regions include the ETV6 and RB1 genes, among others, and exclude the TP53 gene. FISH studies were useful to refine the breakpoints of the translocations, but further studies are needed to determine the role of the involved genes in the neoplastic process.</abstract><cop>Basel, Switzerland</cop><pmid>26509426</pmid><doi>10.1159/000439161</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-5792
ispartof Acta haematologica, 2016-01, Vol.135 (2), p.94-100
issn 0001-5792
1421-9662
language eng
recordid cdi_pubmed_primary_26509426
source MEDLINE; Karger Journals
subjects Aged
Aged, 80 and over
Chromosome Mapping
ETS Translocation Variant 6 Protein
Female
Humans
In Situ Hybridization, Fluorescence
Karyotyping
Male
Middle Aged
Myelodysplastic Syndromes - genetics
Myelodysplastic Syndromes - pathology
Original Paper
Proto-Oncogene Proteins c-ets - genetics
Repressor Proteins - genetics
Retinoblastoma Protein - genetics
Translocation, Genetic
Tumor Suppressor Protein p53 - genetics
title Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T07%3A55%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Refining%20the%20Breakpoints%20of%20Three%20New%20Translocations%20Identified%20in%20Myelodysplastic%20Syndromes&rft.jtitle=Acta%20haematologica&rft.au=Costa,%20Dolors&rft.date=2016-01-01&rft.volume=135&rft.issue=2&rft.spage=94&rft.epage=100&rft.pages=94-100&rft.issn=0001-5792&rft.eissn=1421-9662&rft_id=info:doi/10.1159/000439161&rft_dat=%3Cpubmed_karge%3E26509426%3C/pubmed_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/26509426&rfr_iscdi=true